NGM BIOPHARMACEUTICALS INC Current Assets
NGM BIOPHARMACEUTICALS INC had Current Assets of $156.44 million as of 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2024-03-11
- 2023-12-31: Assets, Current $156.44M.
- 2023-09-30: Assets, Current $177.04M.
- 2023-06-30: Assets, Current $204.40M.
- 2023-03-31: Assets, Current $242.53M.
| Period end | Assets, Current |
|---|---|
| 2023-12-31 | $156.44M 10-K · filed 2024-03-11 |
| 2023-09-30 | $177.04M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $204.40M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $242.53M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $288.86M 10-K · filed 2024-03-11 |
| 2022-09-30 | $315.70M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $318.84M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $337.62M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $379.28M 10-K · filed 2023-02-28 |
| 2021-09-30 | $395.88M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $403.13M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $425.85M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $308.43M 10-K · filed 2022-03-01 |
| 2020-09-30 | $302.24M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $322.62M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $338.31M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $355.25M 10-K · filed 2021-03-15 |
| 2019-09-30 | $364.32M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $368.34M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $199.15M 10-Q · filed 2019-05-16 |
| 2018-12-31 | $214.56M 10-K · filed 2020-03-17 |